February 22, 2022
An American maker of COVID-19 at-home test kits that were recalled this month has been hit with a proposed class action in New York federal court saying the company falsely labeled the tests as approved by the U.S. Food and Drug Administration — which then had to warn the public against using the antigen rapid test.